Cargando…
‘Less is more’ in the Chinese context
Excessive polypharmacy is a common problem around the world, particularly in the treatment of psychiatric disorders. In mainland China use of out-of-date treatment strategies by psychiatric professionals is one of the reasons; others include unrealistically high expectations about the effectiveness...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shanghai Municipal Bureau of Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858509/ https://www.ncbi.nlm.nih.gov/pubmed/27199529 http://dx.doi.org/10.11919/j.issn.1002-0829.215106 |
_version_ | 1782430811705835520 |
---|---|
author | XU, Yifeng |
author_facet | XU, Yifeng |
author_sort | XU, Yifeng |
collection | PubMed |
description | Excessive polypharmacy is a common problem around the world, particularly in the treatment of psychiatric disorders. In mainland China use of out-of-date treatment strategies by psychiatric professionals is one of the reasons; others include unrealistically high expectations about the effectiveness of medications, the dominant role of the doctor in doctor-patient negotiations about treatment, the practice of polypharmacy in Traditional Chinese Medicine (TCM), the profit-driven nature of medical institutions and individuals, the infiltration of pharmaceutical marketing, and a critical lack of relevant research. This commentary considers the cultural factors that need to be addressed when trying to reduce polypharmacy in psychiatry in China. |
format | Online Article Text |
id | pubmed-4858509 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Shanghai Municipal Bureau of Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-48585092016-05-19 ‘Less is more’ in the Chinese context XU, Yifeng Shanghai Arch Psychiatry Decreasing Antipsychotic Polypharmacy Excessive polypharmacy is a common problem around the world, particularly in the treatment of psychiatric disorders. In mainland China use of out-of-date treatment strategies by psychiatric professionals is one of the reasons; others include unrealistically high expectations about the effectiveness of medications, the dominant role of the doctor in doctor-patient negotiations about treatment, the practice of polypharmacy in Traditional Chinese Medicine (TCM), the profit-driven nature of medical institutions and individuals, the infiltration of pharmaceutical marketing, and a critical lack of relevant research. This commentary considers the cultural factors that need to be addressed when trying to reduce polypharmacy in psychiatry in China. Shanghai Municipal Bureau of Publishing 2015-12-25 /pmc/articles/PMC4858509/ /pubmed/27199529 http://dx.doi.org/10.11919/j.issn.1002-0829.215106 Text en Copyright © 2015 by Shanghai Municipal Bureau of Publishing http://creativecommons.org/licenses/by-nc-sa/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ |
spellingShingle | Decreasing Antipsychotic Polypharmacy XU, Yifeng ‘Less is more’ in the Chinese context |
title | ‘Less is more’ in the Chinese context |
title_full | ‘Less is more’ in the Chinese context |
title_fullStr | ‘Less is more’ in the Chinese context |
title_full_unstemmed | ‘Less is more’ in the Chinese context |
title_short | ‘Less is more’ in the Chinese context |
title_sort | ‘less is more’ in the chinese context |
topic | Decreasing Antipsychotic Polypharmacy |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858509/ https://www.ncbi.nlm.nih.gov/pubmed/27199529 http://dx.doi.org/10.11919/j.issn.1002-0829.215106 |
work_keys_str_mv | AT xuyifeng lessismoreinthechinesecontext |